UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ASPIRE BIOPHARMA HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 33-3467744 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 23150 Fashion Drive, Suite 232 Estero, Florida 33928 For the quarterly period ended September 30, 2025 ☐ TRANSITION REPORT ...